Skip to main content
. 2016 Jun 27;7(30):48467–48480. doi: 10.18632/oncotarget.10310

Figure 1. Proposed activation mechanism of nitrophenylalkanoic acid bioreductive prodrugs under convertible reduction.

Figure 1

(A). Structures and molecular formulas of NPPA-PTX (B and C).